HanchorBio
Taipei
About HanchorBio
HanchorBio is a Biotechnology Research firm that is working to revolutionize the treatment of people with cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Total funding: $20.0M
- Funding stage: IPO
- Last round: Series A (Aug 2022)
- Ticker: tsec:7827.TWO
- Website: hanchorbio.com
- Phone: +886(0)2-2792-1366
Industries & Categories
Consumer Research, Health Care, Wellness
Social Profiles
Canonical: https://fsome.com/organization/hanchorbio-5345 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.